ChemicalBook > CAS DataBase List > Atomoxetine EP Impurity C HCl

Atomoxetine EP Impurity C HCl

Product Name
Atomoxetine EP Impurity C HCl
CAS No.
1643684-06-3
Chemical Name
Atomoxetine EP Impurity C HCl
Synonyms
ATOMOXETINE;Atomoxetine EP Impurity C HCl;p-Tolyloxy Atomoxetine Hydrochloride;(R)-N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine;(R)-N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride;(R)-(-)-N-Methyl-3-phenyl-3-(p-tolyoxy)-propylamine hydrochloride;Atomoxetine Impurity 3 Hydrochloride(Atomoxetine EP Impurity C Hydrochloride);(R)-N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride (Atomoxetine Impurity)
CBNumber
CB7346828
Molecular Formula
C17H21NO
Formula Weight
255.35
MOL File
Mol file
More
Less

Atomoxetine EP Impurity C HCl Property

pka
pKa 10.1 (Uncertain)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Atomoxetine EP Impurity C HCl Chemical Properties,Usage,Production

Uses

p-Tolyloxy Atomoxetine Hydrochloride is an impurity of Atomoxetine Hydrochloride(A791400) which is a norepinephrine reuptake inhibitor.

Pharmacokinetics

Atomoxetine is well absorbed from the GItract and cleared primarily by metabolism, with the majority of the dose being excreted into the urine. Atomoxetine is metabolized primarily by CYP2D6 to its major active metabolite, 4-hydroxyatomoxetine, which is eliminated as its glucuronide. Peak plasma concentrations of atomoxetine occur 1 to 2 hours after oral administration. Significant differences are seen in the elimination half-life between normal metabolizers, extensive metabolizers, and poor metabolizers. Atomoxetine exhibited an elimination half-life of 3 to 6 hours for normal and extensive metabolizers and 17 to 21 hours for poor metabolizers. CYP2C19 is the other enzyme primarily responsible for the formation of its minor metabolite N-desmethylatomoxetine.

Clinical Use

Atomoxetine is used as a safe and well-tolerated “nonstimulant” treatment of ADHD in both adults and children and of depression. Among children and adolescents aged 8 to 18 years, atomoxetine was superior to placebo in reducing symptoms of ADHD and in improving social and family functioning symptoms. Oral atomoxetine is promoted as an alternative to conventional ADHD therapy with methylphenidate, dextroamphetamine, and pemoline. It also can be a replacement for bupropion or for TCAs. Onset of action is approximately 7 days.

Side effects

At therapeutic doses, no serious drug-related adverse effects have been encountered. Adverse effects have included modest increases in diastolic blood pressure and heart rate, anorexia, weight loss, somnolence, dizziness, GI effects (nausea), dry mouth, and skin rash.

Enzyme inhibitor

This ADHD drug (FWfree-base = 255.36 g/mol; FWhydrochloride = 291.81 g/mol; CAS 83015-26-3), also known as LY139603, Strattera?, and systematically as (3R) -N-methyl-3- (2-methylphenoxy) -3-phenylpropan-1-amine; (R) -N- methyl-3-phenyl-3- (o-tolyloxy) -propan-1-amine, potently inhibits the presynaptic norepinephrine transporter, Ki = 4.5 nM and is used to treat depression and attention-deficit/hyperactivity disorder. In 2002, Strattera became the first FDA-approved nonstimulant for the treatment of ADHD. The mechanism of action is related to its selective inhibition of presynaptic norepinephrine reuptake in the prefrontal cortex. Atomoxetine demonstrates high affinity and selectivity for norepinephrine transporters, but little or no affinity for neurotransmitter receptors. Atomoxetine demonstrates preferential binding to areas of known high distribution of noradrenergic neurons, such as the fronto-cortical subsystem. Atomoxetine undergoes extensive biotransformation, which is affected by poor metabolism by cytochrome P450 (CYP2D6) in a small percentage of the population. (Note: Atomoxetine was originally named tomoxetine, but was changed to avoid any potential confusion with tamoxifen.) Key Pharmacokinetic Parameters: See Appendix II in Goodman & Gilman’s THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, 12th Edition (Brunton, Chabner & Knollmann, eds.) McGraw-Hill Medical, New York.

Atomoxetine EP Impurity C HCl Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Atomoxetine EP Impurity C HCl Suppliers

Beijing Comparison Pharmaceutical Technology Co., Ltd
Tel
010-010-52878169 15801002657
Email
sales@bjcomparison.com
Country
China
ProdList
4991
Advantage
58
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18042
Advantage
56
Shandong Boluoda Biological Technology Co., Ltd.
Tel
0531-58190570 15863796298
Email
2310993908@qq.com
Country
China
ProdList
1296
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@qq.com
Country
China
ProdList
8377
Advantage
55
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Fax
QQ 3008233717
Email
3008233717@qq.com
Country
China
ProdList
9919
Advantage
12
Jinan blalong chemical co. LTD
Tel
2710913286@.com
Email
1513643261@qq.com
Country
China
ProdList
14246
Advantage
58
Shenzhen ruikai de biotechnology co., ltd.
Tel
0755-61348847 17820674378
Fax
0755-21016893
Email
2682116078@qq.com
Country
China
ProdList
7843
Advantage
58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd
Tel
15850510341
Fax
025-85722793
Email
shiqingran@wzxchem.com
Country
China
ProdList
3731
Advantage
58
Wuxi Helen Biotechnology Co., Ltd.,
Tel
0510-85629785 18013409632
Fax
0510-85625359
Email
sales@reading-chemicals.com
Country
China
ProdList
14081
Advantage
58
Meng Cheng Technology (Shanghai) Co., LTD
Tel
400-820-6829
Email
sales@mitachieve.com
Country
China
ProdList
8860
Advantage
58
Guangzhou Juntang Technology Co., Ltd
Tel
020-36607679 13502246435
Email
sales@dmstandards.com
Country
China
ProdList
10945
Advantage
58
QUALITY CONTROL SOLUTIONS LTD.
Tel
0755-66853366; 13670046396
Email
ORDERS@QCSRM.COM
Country
China
ProdList
24326
Advantage
58
Molcoo Chemicals Inc.
Tel
18627756402
Email
3001051413@qq.com
Country
China
ProdList
9548
Advantage
58
Scinova Biotech(Guangzhou) Co., Ltd.
Tel
13268215580
Email
scinova_sales@163.com
Country
China
ProdList
7023
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81960175-877 18933936954
Email
tianwen.zhan@cato-chem.com
Country
China
ProdList
7735
Advantage
58
Guangzhou Austine Biotechnology Co., LTD
Tel
17727342298
Email
2781109436@qq.com
Country
China
ProdList
2003
Advantage
58
LGC Science (Shanghai) Ltd.
Tel
17717235263
Email
cindy.yang@lgcgroup.com
Country
China
ProdList
15583
Advantage
58
Nanjing Huanuo Biomedical Technology Co., Ltd
Tel
18913906212
Email
2885426135@qq.com
Country
China
ProdList
7010
Advantage
58
Shanghai Haohong Scientific Co., Ltd.
Tel
400-400-8210725
Email
malulu@leyan.com
Country
China
ProdList
39953
Advantage
58
Shenzhen Excellent Biomedical Technology Co., Ltd.
Tel
18318671572
Email
2850803126@qq.com
Country
China
ProdList
4986
Advantage
58
Shanghai Zerui Biotechnology Co., Ltd.
Tel
021-54580889 18321124657
Fax
021-54580889
Email
731997554@qq.com
Country
China
ProdList
10608
Advantage
58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd
Tel
18502726233; 18502726233
Email
3641133981@qq.com
Country
China
ProdList
9705
Advantage
58
Shenzhen Qingtian Biotechnology Co, Ltd.
Tel
18823167005 18162969855
Email
744288988@qq.com
Country
China
ProdList
2629
Advantage
58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd
Tel
18102736234 18102736234
Email
2208093734@qq.com
Country
China
ProdList
7664
Advantage
58
Hubei Moco Chemical Co., Ltd.
Tel
18627753421 18576690171
Fax
QQ:3001051413
Email
3001009495@qq.com
Country
China
ProdList
11192
Advantage
58
Cato Research Chemicals Inc.
Tel
13342851930
Email
3008394369@qq.com
Country
China
ProdList
15726
Advantage
58
Hubei Ruinuo Pharmaceutical Technology Co., Ltd
Tel
13165688766
Fax
0714-5316360
Email
3008058303@qq.com
Country
China
ProdList
3009
Advantage
58
China National Standard Pharmaceutical Corporation Limited
Tel
+8615391658522
Email
overseasales@yongstandards.com
Country
China
ProdList
11922
Advantage
58
Shanghai Hao Zhun Biological Technology Co., Ltd.
Tel
--
Fax
--
Email
info@zzsrm.com
Country
CHINA
ProdList
6650
Advantage
58

1643684-06-3, Atomoxetine EP Impurity C HClRelated Search:


  • ATOMOXETINE
  • Atomoxetine EP Impurity C HCl
  • (R)-N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine
  • (R)-N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride
  • p-Tolyloxy Atomoxetine Hydrochloride
  • (R)-(-)-N-Methyl-3-phenyl-3-(p-tolyoxy)-propylamine hydrochloride
  • Atomoxetine Impurity 3 Hydrochloride(Atomoxetine EP Impurity C Hydrochloride)
  • (R)-N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride (Atomoxetine Impurity)
  • 1643684-06-3